P-113 FIGHT-302: Phase 3 study of first-line pemigatinib vs gemcitabine + cisplatin for cholangiocarcinoma with FGFR2 fusions or rearrangement T. S. Bekaii-Saab,Juan W. Valle,E. Van Cutsem,Lorenza Rimassa,J. Furuse,Tatsuya Ioka,Teresa Macarulla,John Bridgewater,Harpreet Wasan,Mitesh J. Borad,Arndt Vogel,Christine F. Lihou,Hui-Ling Zhen,Ping Jiang, P Langmuir,Davide MelisiAnnals of Oncology（2021）引用 0|浏览5暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
